Risk of tuberculosis is higher with anti–tumor necrosis factor monoclonal antibody therapy than with soluble tumor necrosis factor receptor therapy: The three‐year prospective french research axed on tolerance of biotherapies registryFlorence Tubach, Xavier Mariette|Arthritis & Rheumatism|2009Cited by 631
2021 DORIS definition of remission in SLE: final recommendations from an international task forceRonald van Vollenhoven, Y K Onno Teng, Bernardo A. Pons‐Estel et al.|Lupus Science & Medicine|2021Cited by 340
Consensus gene modules strategy identifies candidate blood-based biomarkers for primary Sjogren's diseaseCheïma Boudjeniba, Étienne Becht, Perrine Soret et al.|medRxiv|2023Cited by 0